In the 2nd recurrence PD-L1 expression (3.20 NE IQR 1.3-3.9) was further reduced (3.38 %) in comparison to the fist recurrence (53% less expression of PD-L1 in comparison to de-novo tumours, p=0.00033). Here, CD274 is linked to neoplasm.